focus -WSS

focus

author：leisure time 2025-09-30 16:29:18 - browse：95979

RHONA WISE/AFP via Getty Images

WASHINGTON — Drugmakers are doing everything to tap the bottomless well of demand for new obesity drugs, and they might get some government help. The agency that regulates Obamacare insurance is considering a technical change that would require insurers to cover obesity drugs in a market of more than 20 million Americans.

Weight loss drugs are a blessing for patients, a boon for drugmakers, and a potentially huge expense for insurers and taxpayers. Insurers have been slow to cover the drugs, called GLP-1 agonists, and without insurance, it costs upward of $16,000 annually for a drug that must be taken indefinitely.

There is a lot of demand for the drugs, but there are barriers to coverage. Medicare by law is prohibited from paying for obesity drugs. State Medicaid programs don’t have to cover them, so most don’t.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Inequities make cancer less preventable for women: report

WSS

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

Researchers use wearables data and AI to predict preterm birth risk

Senator probes 340B programs at Cleveland Clinic, Bon Secours

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Why palliative psychiatry is worth discussing

knowledge

focus

explore

Dobbs anniversary: the lost opportunity of abortion as health care

Shingles, which affected Dianne Feinstein, is on the rise

Affirmative action in medical school literally saved lives

6 phony surgeries that take placebo to the extreme

Medicare details structure of new drug price negotiation program

He's a Nobel laureate. Critics say he was misleading on Covid

In Memoriam: Notable people who died in 2023

After a drawn out lobbying fight, ARPA

Bright Health sells Medicare Advantage business to Molina

A new nitrogen execution bill also undermines medical licensing

entertainment

Medicaid, Medicare dual

Did you have Obamacare on your GOP debate bingo card?

Listen: Who gets the credit for GLP

Kaiser Permanente unions announce official strike date

Alabama IVF ruling threatens families facing fatal genetic disease

Health tech startups drop sharply from 2021 highs

leisure time

Wikipedia

hotspot

focus